Amine MAROUF

Amine MAROUF has a diverse range of work experience in the field of healthcare and innovation. Amine is currently working as a Principal at Kurma Partners since June 2017, where they are responsible for market watch, deal opportunity sourcing, and relationship management with various healthcare stakeholders in Europe. Amine is also involved in investment committees, jury memberships, and speaking engagements for national innovation programs and events.

In addition to their role at Kurma Partners, Amine MAROUF is a Life Sciences investor at Paris Saclay Seed Fund since June 2017. Amine is also involved in multiple board member and lead investor roles at NaoX Technologies and Mila since December 2021 and December 2020 respectively. Amine serves as a board observer and co-investor at Lucine and FeetMe since October 2020.

Prior to these roles, they worked as an Expert and Jury member at Bpifrance from January 2018. Amine also has experience as an Entrepreneur/Innovation Consultant at Le Belvedere since June 2015. Additionally, they worked as a Consultant life sciences at BearingPoint from January 2017 to May 2017 and as a Business analyst oncology at AstraZeneca from July 2016 to December 2016.

Amine Marouf has a diverse education history. Amine attended ESSEC Business School from 2009 to 2011, where they earned a Master of Science degree in Management. Prior to that, they studied at Université Paris Cité from 2006 to 2009, completing a Magistère Européen de Génétique degree in Genetics. During the same period, they also obtained a Master in Research degree in Health & Applied Sciences. Before their time at Université Paris Cité, Amine studied Biomedical sciences at the same institution from 2004 to 2006, completing a two-year degree. Further information regarding their educational background is unavailable for the Lycée Rabelais. In addition to their degrees, Amine Marouf holds a Certification professionnelle AMF des acteurs de marchés, provided by the Autorité des marchés financiers (AMF) in France. The details of when they obtained this certification are unknown.